Burkitt-like lymphomas in AIDS patients: Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas

Journal of Clinical Oncology

Volumn 16, Issue 12, 1998, Pages 3788-3795

  Davi, F ^a   Delecluse, H J ^a   Guiet, P ^a   Gabarre, J ^a   Fayon, A ^a   Gentilhomme, O ^a   Felman, P ^a   Bayle, C ^a   Berger, F ^a   Audouin, J ^a   Bryon, P A ^a   Diebold, J ^a   Raphael M ^a  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD70 ANTIGEN; IMMUNOGLOBULIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN BCL 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032421356     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.12.3788     Document Type: Article

References (51)

1. Knowles DM, Chamulak GA, Subar M, et al: Lymphoid neoplasia associated with acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 108:744-753, 1988
2. Beral V, Paterman T, Berkelman R, et al: AIDS-associated non-Hodgkin's lymphoma. Lancet 337:805-809, 1991
3. Levine AM: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20, 1992
4. Herndier BG, Kaplan LD, McGrath MS: Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049, 1994
5. Raphael M, Gentilhomme O, Tulliez M, et al: Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 115:15-20, 1991
6. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al: AIDS-related lymphoma: Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149-163, 1991
7. Gaidano G, Carbone A: AIDS-related lymphomas: From pathogenesis to pathology. Br J Haematol 90:235-243, 1995
8. Boyle MJ, Swanson CE, Turner JJ, et al: Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Br J Haematol 76:506-512, 1990
9. Roithmann S, Andrieu JM: Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. Eur J Cancer 28A:1501-1508, 1992
10. Carbone A, Gloghini A, Gaidano G, et al: AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 103:561-567, 1995
11. Subar M, Neri A, Inghirami G, et al: Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667-671, 1988
12. Shiramizu B, Herndier B, Meeker T, et al: Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. J Clin Oncol 10:383-389, 1992
13. Ballerini P, Gaidano G, Gong JZ, et al: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166-176, 1993
14. Shibata D, Weiss LM, Hernandez AM, et al: Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81:2102-2109, 1993
15. Bhatia K, Spangler G, Gaidano G, et al: Mutations in the coding region of c-mvc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84:883-888, 1994
16. Raphael M, Audouin J, Lamine M, et al: Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Am J Clin Pathol 101:773-782, 1994
17. Delecluse HJ, Raphael M, Magaud JP, et al: Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. Blood 82:552-563, 1993
18. Berard C, O'Conor GT, Thomas LB, et al: Histopathological definition of Burkitt's tumor. Bull World Health Organ 40:601-607, 1969
19. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
20. Grogan TM, Warnke RA, Kaplan HS: A comparative study of Burkitt's and non-Burkitt's "undifferentiated" malignant lymphoma: Immunologic, cytochemical, ultrastrutural, cytologic, histopathologic, clinical and cell culture features. Cancer 49:1817-1828, 1982
21. Miliauskas JR, Berard CW, Young RC, et al: Undifferentiated non-Hodgkin's lymphoma (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction. Cancer 50:2115-2121, 1982
22. Payne CM, Grogan TM, Cromey DW, et al: An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. Lab Invest 57:200-218, 1987
23. Kelly DR, Nathwani BN, Griffith RC, et al: A morphologic study of childhood lymphoma of the undifferentiated type. Cancer 59:1132-1137, 1987
24. Pavlova Z, Parker JW, Taylor CR, et al: Small non cleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. Cancer 59:1892-1902, 1987
25. Hutchison RE, Murphy SB, Fairclough DL, et al: Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Cancer 64:23-28, 1989
26. Harris NL, Jaffe ES, Stein H, et al: A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
27. Jaffe ES, Harris NL, Chan JKC, et al: Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 21:114-121, 1997
28. Yano T, van Krieken J, Magrath IT, et al: Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79:1282-1290, 1992
29. Lee JT, Innes DJ, Williams ME: Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non Hodgkin's lymphoma. J Clin Invest 84:1454-1459, 1989
30. Wiels J, Fellous M, Tursz T: Monoclonal antibody reacting with Burkitt's lymphoma associated antigen. Proc Natl Acad Sci USA 78:6485-6488, 1981
31. Cleary ML, Chao J, Warnke R, et al: Immunoglobulin gene rearrangement as diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 81:593-596, 1984
32. Eick D, Piechaczyk M, Henglein B, et al: Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J 4:3717-3725, 1985
33. Henglein B, Synovizt H, Groitl P, et al: Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol Cell Biol 9:2105-2113, 1989
34. Polack A, Hartl G, Zimber U, et al: A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 27:279-288, 1984
35. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889, 1986
36. Gribben J, Freedman A, Woo S, et al: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275-3280, 1991
37. Croce CM, Nowell PC: Molecular genetics of human B cell neoplasia. Adv Immunol 38:245-274, 1986
38. Shiramizu B, Barriga F, Neequaye J, et al: Patterns of chromosomal breakpoints locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 77:1516-1526, 1991
39. Kaplan LD, Abrams DI, Feigal E, et al: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719-724, 1989
40. Levine AM, Sullivan-Halley J, Pike MC, et al: HIV-related lymphoma: Prognostic factors predictive of survival. Cancer 68:2466-2472, 1991
41. Vaccher E, Tirelli U, Spina M, et al: Age and serum lactate dehydrogenase level are independant prognostic factors in human immunodeficiency virus-related non Hodgkin's lymphoma: A single-institute study of 96 patients. J Clin Oncol 14:2217-2223, 1996
42. Kaplan LD, Strauss DJ, Testa MA, et al: Low-dose compared with standard-dose m-BACOB chemotherapy for non Hodgkin's lymphoma associated human immunodeficiency virus infection. N Engl J Med 336:1641-1648, 1997
43. Hamilton-Dutoit S, Rea D, Raphael M, et al: Epstein-Barr virus latent gene espression and tumor cell phenotype in AIDS-related non-Hodgkin's lymphoma. Am J Pathol 143:1072-1085, 1993
44. Gaidano G, Pastore C, Gloghini A, et al: Genetic heterogeneity of AIDS-related small non-cleaved lymphoma. Br J Haematol 98:726-732, 1997
45. Felman P, Bryon PA, Gentilhomme O, et al: Distinction of subgroups by morphometric analysis of the characteristics of 55 cell lines. Anal Quant Cytol Histol 7:275-282, 1985
46. Rowe M, Rooney CM, Edwards CF, et al: Epstein-Barr virus status and tumor cell phenotype in sporadic Burkitt's lymphoma. Int J Cancer 37:367-373, 1986
47. Rowe M, Rowe DT, Gregory CD, et al: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-2751, 1987
48. Cutrona G, Ulivi M, Fais F, et al: Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J Exp Med 181:699-711, 1995
49. Gregory CD, Murray RJ, Edwards CF, et al: Downregalation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus -positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 167:1811-1824, 1988
50. Kishimoto T: The biology of interleukin-6. Blood 74:1-10, 1989
51. Emilie D, Coumbaras J, Raphael M, et al: Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus - negative patients. Blood 80:498-504, 1992